Latest Financials News

Shine Justice reshuffles its top management as Simon Morrison steps down from Managing Director to Executive Director to spearhead international growth, particularly in its burgeoning mass torts program, while Carolyn Barker AM maintains overall CEO leadership.

Wildcat Resources (ASX: WC8) has expanded its Bolt Cutter Central lithium discovery footprint beyond 2.3km with multiple high-grade spodumene intercepts, while advancing the Definitive Feasibility Study for its Tabba Tabba Project. The company maintains a strong cash position of A$43.3 million as it prepares for further drilling and development milestones.

Orthocell has secured approval for its Remplir™ nerve repair device to be used across 221 U.S. military and veterans hospitals, marking a major step in its U.S. commercial expansion. The approval follows clinical validation in conflict zones, positioning Orthocell to deepen penetration into defence healthcare.

Duratec's joint venture with Ertech has clinched a $281 million contract to upgrade submarine infrastructure at HMAS Stirling, marking a major step in Australia's AUKUS defence preparations.

Nyrada has secured ethics approval to start its Phase IIa trial of Xolatryp in heart attack patients, with recruitment beginning in April 2026. The biotech also bolsters its cash position to AU$6.74 million and pursues new oncology indications.

Cavalier Resources’ 2026 Pre-Feasibility Study update boosts the Stage 1 NPV of its Crawford Gold Project to A$77.2 million at A$6,500/oz gold, reflecting resilience amid supply chain pressures. The project maintains its ore reserve and pit design, with financing negotiations advancing.

Hiremii Limited has landed its initial paying customers for its AI-powered workforce intelligence platform, marking a pivotal step in its shift from recruitment services to a SaaS technology provider in energy and infrastructure sectors.

Nufarm reports a robust first half of FY26 with underlying EBITDA rising 17% and net debt falling by $130 million, while new CEO Rico Christensen initiates a $50 million cost savings program as part of a strategic refresh.

Collins Foods has formalised a settlement deed to resolve a long-running employee class action over 10-minute rest breaks, with Federal Court approval still pending.

Virgin Australia navigates a doubling of jet fuel prices with robust hedging and fare adjustments, maintaining its FY26 earnings outlook despite rising costs.

Evolution Mining (ASX: EVN) ended March 2026 with a net cash position of $42 million and a $1.37 billion cash balance, driven by strong cash flow from high-margin operations and on-track production.

Genetic Signatures has locked in a 10-year supply deal with Denmark’s Hvidovre Hospital for its EasyScreen™ Pan-Enteric assay, marking a significant step in its European expansion. The agreement covers 28,000 tests in the first year with growth expected, leveraging the company’s proprietary 3base® technology to streamline complex gastrointestinal pathogen detection.